NCT05660954 2026-04-02CABOTHYROIDGrupo Espanol de Tumores NeuroendocrinosPhase 2 Active not recruiting41 enrolled
NCT03170960 2025-08-17Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsExelixisPhase 1 Active not recruiting914 enrolled